Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Psoriasis severity | |||||
Systematic review |
Number of people in analysis not reported, psoriasis severity not reported 9 RCTs in this analysis |
Psoriasis severity scores
3–8 weeks
with vitamin D derivatives with potent topical corticosteroids |
SMD +0.06 95% CI –0.12 to +0.24 Significant statistical heterogeneity reported among trials (P <0.01) |
Not significant |